Journal Logo

LETTERS

Hypercoagulability Due to Homocystinuria in a Case of Head and Neck Reconstruction Resolved with Combined Systemic Therapy

di Spilimbergo, Stefano Spanio M.D., D.M.D.; Rampazzo, Antonio M.D.; Squaquara, Roberto M.D.; Penzo, Michelangelo M.D.; Padula, Ernesto M.D.

Author Information
Plastic and Reconstructive Surgery: April 2008 - Volume 121 - Issue 4 - p 1508-1509
doi: 10.1097/01.prs.0000305361.01499.f6
  • Free

Sir:

We read with great interest an article recently published in Plastic and Reconstructive Surgery about a case of free flap failure in a patient with homocystinuria.1 The authors faced multiple arterial thrombi during toe-to-hand transfer in their young patient. They tried thrombectomy and multiple local infusions of streptokinase and tissue plasminogen activator, but eventually they could not save the flap.

We experienced a similar case in a patient operated on for a squamous cell carcinoma of the floor of the mouth. After resection, he was reconstructed with a free anterolateral thigh musculocutaneous flap. Unfortunately, this flap failed due to venous and arterial thromboses. We tried to overcome the problem with arterial infusion of 1000 IU of streptokinase with opened veins and 4000 IU of subcutaneous heparin postoperatively, but we had no success and explained this failure as a technical error.

We then decided to perform another anterolateral thigh musculocutaneous flap from the contralateral side. At this stage, multiple arterial thromboses after every anastomosis with the facial, lingual, and superior thyroid arteries presented. Sometimes thrombosis was evident even before anastomosis. Intraoperative Doppler ultrasound of the carotid artery showed normal flow.

Due to this unknown hypercoagulable state, we started with empirical systemic therapy: 50 mg of tissue plasminogen activator intravenously, 0.1 μg/kg per minute continuous intravenous infusion of tirofiban (inhibits platelet aggregation) for 12 hours, and 8000 IU/day of continuous intravenous infusion of heparin. Arterial thrombosis resolved in about 10 minutes, and we then successfully performed vessel repair.

From the twelfth postoperative hour until the seventh postoperative day, prophylactic intravenous heparin was administered. From the seventh to the fourteenth postoperative day, 2000 IU of subcutaneous heparin was given three times a day.

The postoperative course was uneventful, and after 25 days the patient was discharged. A coagulation work-up was positive for elevated serum homocysteine, consistent with moderate homocystinuria. We agree with the authors that hypercoagulability syndromes2–5 should be included in the differential diagnosis of flap loss, and we think that when faced with this problem only an associated systemic therapy with thrombolytic, antiaggregant, and heparin can resolve the problem. Bleeding could be the main disadvantage, so the whole history, examination, and risk-benefit ratio should be taken into consideration.

Stefano Spanio di Spilimbergo, M.D., D.M.D.

Antonio Rampazzo, M.D.

Roberto Squaquara, M.D.

Unità Operativa di Chirurgia Maxillo-Facciale

Michelangelo Penzo, M.D.

Unità Operativa di Cardiologia

Ernesto Padula, M.D.

Unità Operativa di Chirurgia Maxillo-Facciale

Ospedale S. Bortolo

Vicenza, Italia

REFERENCES

1. Labow, B. I., Greene, A. K., and Upton, J. Homocystinuria: An unrecognized cause of microvascular failure. Plast. Reconstr. Surg. 120: 6e, 2007.
2. Ayala, C., and Blackwell, K. E. Protein C deficiency in microvascular head and neck reconstruction. Laryngoscope 109: 259, 1999.
3. Wilson, K. M., McCaw, R. B., Leo, L., et al. Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27: 233, 2007.
4. Bick, R. L. Coagulation abnormalities in malignancy: A review. Semin. Thromb. Hemost. 18: 353, 1992.
5. Nand, S. Hemostasis and cancer. Cancer J. 6: 1, 1993.

Section Description

Letters to the Editor, discussing material recently published in the Journal, are welcome. They will have the best chance of acceptance if they are received within 8 weeks of an article's publication. Letters to the Editor may be published with a response from the authors of the article being discussed. Discussions beyond the initial letter and response will not be published. Letters submitted pertaining to published Discussions of articles will not be printed. Letters to the Editor are not usually peer reviewed, but the Journal may invite replies from the authors of the original publication. All Letters are published at the discretion of the Editor.

Authors will be listed in the order in which they appear in the submission. Letters should be submitted electronically via PRS' enkwell, at www.editorialmanager.com/prs/.

We reserve the right to edit Letters to meet requirements of space and format. Any financial interests relevant to the content of the correspondence must be disclosed. Submission of a Letter constitutes permission for the American Society of Plastic Surgeons and its licensees and asignees to publish it in the Journal and in any other form or medium.

The views, opinions, and conclusions expressed in the Letters to the Editor represent the personal opinions of the individual writers and not those of the publisher, the Editorial Board, or the sponsors of the Journal. Any stated views, opinions, and conclusions do not reflect the policy of any of the sponsoring organizations or of the institutions with which the writer is affiliated, and the publisher, the Editorial Board, and the sponsoring organizations assume no responsibility for the content of such correspondence.

©2008American Society of Plastic Surgeons